Skip to main content

Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.

Grove EL, Hvas AM, Mortensen SB, Larsen SB, Kristensen SD

Publication: J Thromb Haemost (2011) • Vol 9 • Page 185-91PMID: 20955349View on PubMed

Purpose

The purpose of this paper was to determine the effects of platelet turnover on the antiplatelet activity of aspirin in patients with coronary artery disease (CAD).

Conclusion

There was no correlation between platelet aggregation and immature platelet fraction (IPF). Using multiple electrode aggregometry (MEA), platelet aggregation correlated with immature platelet count (IPC), sP-selectin, platelet count with all inducers, and with mean platelet volume (MPV), except when induced with adenosine diphosphate (ADP). No correlations with aggregation were observed using the VerifyNow system. Patients who had diabetes in addition to CAD had higher levels of serum thromboxane B2, sP-selectin, and thrombopoietin than patients with CAD but not diabetes. IPC and IPF were increased 17-21% in patients with diabetes and in smokers.

Studies (1)

Purpose

The purpose of this study was to determine the effects of photometer type, diabetes, and smoking on measures of platelet aggregation and activation in patients with CAD taking aspirin.

Summary of Findings

There was no correlation between platelet aggregation and IPF. Using the MEA system, platelet aggregation correlated with IPC (r=0.31-0.35, p<0.0001), sP-selectin (r=0.19, p=0.014), and platelet count (r=0.45-0.68, p<0.0001) with all inducers, and with MPV (r=0.17-0.23, p<0.05) except when induced with ADP. No correlations with aggregation were observed using the VerifyNow system. Patients who had diabetes in addition to CAD had higher levels of serum thromboxane B2 (p<0.0001), sP-selectin (p<0.05) and thrombopoietin (p<0.001) than patients with CAD but not diabetes. IPC and IPF were increased 17-21% in diabetics and smokers (p<0.05).
  • Biospecimens

    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Cardiovascular Disease
    Diabetes Type 2
  • Platforms

    Cell count/volumePhotometer
    Cell count/volumeHematology/ auto analyzer
    Cell count/volumeFlow cytometry
    GlycoproteinELISA
    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Coronary artery disease
    Type II diabetes and coronary artery disease
    PreaquisitionOther drugs
    Aspirin
    Non-smoker
    Smoker
    Photometer SpecificReaction solution
    Adenosine diphosphate (ADP)
    Arachidonic acid
    Collagen
    Photometer SpecificTechnology platform
    Multiple electrode aggregometry
    VerifyNow